| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/06/1997 | US5627283 Antithrombin compounds |
| 05/06/1997 | US5627197 Piperidino- or piperazino-substituted oxazolidinone, thiazolidinones or imidazolidinones |
| 05/06/1997 | US5626869 Pharmaceutical composition containing a defined lipid system |
| 05/06/1997 | US5626860 Treatment of diabetes and reduction of fat stores |
| 05/02/1997 | EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity |
| 05/02/1997 | EP0770626A2 Method for purifying thrombomodulin |
| 05/02/1997 | EP0770602A2 Crystals of piperidine derivatives, intermediates for production of the same, and process for producing the same |
| 05/02/1997 | EP0770396A2 Use of new factor VIII coagulant polypeptides |
| 05/02/1997 | EP0770129A1 Zinc finger protein derivatives and methods therefor |
| 05/02/1997 | EP0769962A1 Method of attenuating arterial stenosis |
| 05/02/1997 | EP0769952A1 Chicken infectious anemia virus vaccine |
| 05/01/1997 | WO1997015661A1 Microporous pathogen-killing composition |
| 05/01/1997 | WO1997015595A1 Method of mobilizing hematopoietic stem cells |
| 05/01/1997 | WO1997015594A1 Novel chemokine for mobilizing stem cells |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015568A1 Fibrinogen receptor antagonist |
| 05/01/1997 | WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015328A1 Pharmaceutical compositions containing platelet aggregation inhibitors |
| 05/01/1997 | WO1997015323A1 Infusions of neuroprotectants and thrombolytic agents |
| 05/01/1997 | WO1997015320A1 Novel uses of mammalian ctla-8 and related reagents |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235360A1 Novel chemokine for mobilizing stem cells |
| 05/01/1997 | CA2233861A1 Fibrinogen receptor antagonist |
| 05/01/1997 | CA2229617A1 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation |
| 04/29/1997 | US5625067 Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use |
| 04/29/1997 | US5624940 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
| 04/29/1997 | US5624685 High polymer gel and vascular lesion embolizing material comprising the same |
| 04/29/1997 | US5624668 Iron dextran formulations |
| 04/24/1997 | WO1997014806A2 Delivery of biologically active polypeptides |
| 04/24/1997 | WO1997014432A1 Modulation of integrin-mediated signal transduction |
| 04/24/1997 | WO1997014417A1 Fibrinogen receptor antagonists |
| 04/24/1997 | WO1997014306A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | WO1997008934A3 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/24/1997 | CA2235245A1 Low molecular weight cell, bone marrow and immune stimulants |
| 04/24/1997 | CA2234967A1 Fibrinogen receptor antagonists |
| 04/24/1997 | CA2207973A1 Modulation of integrin-mediated signal transduction |
| 04/23/1997 | EP0769554A2 Human CNP gene and precursor protein |
| 04/23/1997 | EP0769023A1 Retinoic acid receptor epsilon |
| 04/23/1997 | EP0768892A1 Thrombolytic composition |
| 04/23/1997 | EP0768886A1 Endothelial lining effects and treatment of vasospastic disorders |
| 04/23/1997 | EP0670825B1 Nitric esters having a pharmacological activity and process for their preparation |
| 04/23/1997 | EP0621869B1 Human kunitz-type protease inhibitor variants |
| 04/23/1997 | CN1148408A Hematopoietic Protein and materials and method for making it |
| 04/23/1997 | CN1148338A Increasing fetal hemoglobin level using carboxylic esters |
| 04/23/1997 | CN1034663C Method for preparing hemoregulatory peptides |
| 04/22/1997 | US5623073 Benzimidazole compounds |
| 04/22/1997 | US5623064 Purity; removal of protein |
| 04/22/1997 | US5622988 Administering xanthene derivative hemostatic agent |
| 04/22/1997 | US5622939 Glucan preparation |
| 04/22/1997 | US5622931 Human tissue factor related DNA segments, polypeptides and antibodies |
| 04/22/1997 | US5622834 Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture |
| 04/17/1997 | WO1997013771A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/17/1997 | WO1997013757A1 Pyrazolone derivatives |
| 04/17/1997 | WO1997013511A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/17/1997 | CA2234560A1 Pyrazolones |
| 04/17/1997 | CA2234404A1 Methods of inhibiting plasminogen activator inhibitor 1 |
| 04/16/1997 | EP0768302A2 Hydroxypyridinones |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767666A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 04/16/1997 | EP0387290B1 Novel human tissue-type plasminogen activator variant |
| 04/16/1997 | CN1147512A Substituted 4H-pyrans |
| 04/16/1997 | CN1147506A Benzoazepine-Benzooxaazepine-Benzothiaazepine-N-acetate derivant |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621000 Nitric esters having a pharmacological activity and process for their preparation |
| 04/15/1997 | US5620991 Aromatic amidine derivatives and salts thereof |
| 04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620688 Methods of inhibiting the activation of Factor XIII |
| 04/15/1997 | US5620685 Protein mixtures containing stem cell factors, interleukins and granulocyte macrophage colony stimulating factors |
| 04/10/1997 | WO1997012985A2 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | WO1997012979A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | WO1997012978A1 NOVEL c-mpl RECEPTOR AGONISTS |
| 04/10/1997 | WO1997012904A1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012898A1 Novel platelet activation protein |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012855A1 Butyrate prodrugs of lactic acid |
| 04/10/1997 | WO1996041868A3 Prothrombin derivatives |
| 04/10/1997 | WO1996026961A3 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 04/10/1997 | CA2234061A1 Multi-functional hematopoietic receptor agonists |
| 04/10/1997 | CA2234059A1 Novel c-mpl receptor agonists |
| 04/10/1997 | CA2234045A1 Interleuken-3 (il-3) receptor agonists |
| 04/10/1997 | CA2233994A1 Novel platelet activation protein |
| 04/10/1997 | CA2233606A1 Butyrate prodrugs of lactic acid |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766563A1 Agents affecting thrombosis hemostasis |
| 04/09/1997 | EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | CN1147261A Factor Xa inhibitors |
| 04/09/1997 | CN1147250A Naphthalene derivs. as prostaglandin I2 agonists |
| 04/09/1997 | CN1147205A Antithrombotic agents |
| 04/08/1997 | US5618941 Benzenealkanoic acids for cardiovascular diseases |
| 04/08/1997 | US5618843 Inhibit platelet aggregation |
| 04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 04/08/1997 | US5618713 Mutants of human antithrombin III |
| 04/08/1997 | US5618698 Growing host cells transformed or transfected with specified isolated dna sequence, isolating erythropoietin product |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |